Abstract
Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Mini-Reviews in Medicinal Chemistry
Title: Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor
Volume: 8 Issue: 3
Author(s): Georgios A. Spyroulias, Georgios A. Dalkas, Athanasios Papakyriakou and Alexios Vlamis-Gardikas
Affiliation:
Keywords: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease
Abstract: Anthrax lethal factor (LF), mitogen-activated protein kinase kinase (MAPKK), small molecular weight inhibitors, structure-based drug discovery, zinc-metalloprotease.
Export Options
About this article
Cite this article as:
Spyroulias A. Georgios, Dalkas A. Georgios, Papakyriakou Athanasios and Vlamis-Gardikas Alexios, Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor, Mini-Reviews in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/138955708783744083
DOI https://dx.doi.org/10.2174/138955708783744083 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dysfunction of Pulmonary Vascular Endothelium in Chronic Obstructive Pulmonary Disease: Basic Considerations for Future Drug Development
Current Drug Metabolism Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews]
Mini-Reviews in Medicinal Chemistry Chalcones Incorporated Pyrazole Ring Inhibit Proliferation, Cell Cycle Progression, Angiogenesis and Induce Apoptosis of MCF7 Cell Line
Anti-Cancer Agents in Medicinal Chemistry Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities
Medicinal Chemistry Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Current Drug Metabolism Comparative Studies of the Antioxidant Effects of Cis- and Trans- Resveratrol
Current Medicinal Chemistry Amphotericin B: From Derivatives to Covalent Targeted Conjugates
Mini-Reviews in Medicinal Chemistry The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry On the Search for Skin Gene Therapy Strategies of Xeroderma Pigmentosum Disease
Current Gene Therapy Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism Emerging Potential of Citrus Flavanones as an Antioxidant in Diabetes and its Complications
Current Topics in Medicinal Chemistry The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Synthesis of 1,5-Diarylpyrazoles as Potential COX-2 Inhibitors with Nitric Oxide Releasing Ability
Letters in Drug Design & Discovery Designing and Testing New Therapeutic Modalities for Treatment of Inflammatory Bowel Disease: Role of Experimental Animal Models
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Biosafety of Recombinant Adeno-associated Virus Vectors
Current Gene Therapy